A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimen. [electronic resource]
- Oncology reports Dec 2007
- 1613-321 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1021-335X
Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols--therapeutic use Bayes Theorem Body Surface Area Body Weight Camptothecin--administration & dosage Digestive System Neoplasms--drug therapy Female Fluorouracil--administration & dosage Humans Irinotecan Male Middle Aged Models, Biological Neoplasm Metastasis Reproducibility of Results